SCHEMBL5280989

SCHEMBL5280989

COc1cc(NS(=O)(=O)c2ccc(I)cc2)cc(OC)c1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.55
HTT P42858 4/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
PKM P14618 3/20 0.55
MAPK1 P28482 2/20 0.55
HTR6 P50406 4/20 0.54
ALOX15 P16050 2/20 0.54
ALDH1A1 P00352 2/20 0.54
KDM4E B2RXH2 1/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
MAPT P10636 2/20 0.51
TP53 P04637 1/20 0.51
THRB P10828 1/20 0.51
CA12 O43570 1/20 0.49
CA9 Q16790 1/20 0.49
FAM20C Q8IXL6 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CYP19A1 P11511 1/20 0.48
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28864522 0.86 LMNA (0.68) LMNAHTTSMN1; SMN2PKMMAPK1
SCHEMBL6048148 0.86 CYP19A1 (0.65) LMNAHTTSMN1; SMN2PKMMAPK1
SCHEMBL6350411 0.85 HTR6 (0.65) LMNAHTTSMN1; SMN2PKMMAPK1
SCHEMBL213547 0.85 LMNA (0.77) LMNAHTTSMN1; SMN2PKMMAPK1
SCHEMBL6073370 0.84 CA12 (0.59) LMNAHTTSMN1; SMN2PKMMAPK1
SCHEMBL6341219 0.83 LMNA (0.79) LMNAHTTSMN1; SMN2PKMMAPK1
SCHEMBL5289106 0.81 SMN1; SMN2 (0.65) LMNAHTTSMN1; SMN2PKMMAPK1
SCHEMBL6349559 0.81 MAPK1 (0.67) LMNAHTTSMN1; SMN2PKMMAPK1
SCHEMBL6343830 0.81 MEN1 (0.67) LMNAHTTSMN1; SMN2PKMMAPK1
SCHEMBL2215125 0.79 CA1 (0.62) LMNAHTTSMN1; SMN2PKMMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112876388-B GPR120 agonist and preparation method and application thereof 山东大学 2023-03-31 CN disclosed
CN-112876388-A GPR120 agonist and preparation method and application thereof 山东大学 2021-06-01 CN disclosed
EP-1863804-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2007-12-12 EP disclosed
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US disclosed
WO-2006102760-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2006-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264415-A1 Inhibitors of histone deacetylase HDAC1, HDAC3, HDAC11 LMNA 851/4885HTT 846/4885SMN1; SMN2 3733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.